radio therapy dec11

8/11/2019 Radio Therapy Dec11

1/5

FINALEXAM

DECEMBER

011

Time

:3

hours

Max.

Marks

:

100

Attemptall questions n order.

Each

question

carries

10

marks.

NATIONAL OARD

OF EXAMINATIONS

RADIO

THERAPY

PAPER-

RTH/D/I1t41t1

1.

a.

What

s

evidence

ollection

n

oncological

ciences?

b.

How

do

you

carry

out Interim

nalyses?

c. Discuss

n

brief

ulcc

(lAcR)

recommendations

or follow

in

cancer

atients?

2.

a.

Describe

atterson

Parker

Rules.

b. What

are

heir

different

pplications

n Brachytherapy?

3. a. Enumerate he various

aspects

of

Radiation

reatment

planning.

b. Describe

ts importance

n

the

basis

of

fundamentals

f

ICRU.

4.

what

are

various

methods

appried

or

brachytherapy

ose

calculations

n

gynaecological

ancers?

What

s'Gynaecological

ncologic

mergencies'?

Enumerate

hem.

Describe

management

f one

of them.

compare

in

a tabular

orm

various

radiation

ractionation

schedules

nd

heir

specific

ndications.

Describe

n

brief

heir

early

and

ate

normar

issue

ffects.

Define

nd

describe

edge

ilters

nd

compensators.

Procedures

nvolved

n

deciding

r

prescribing

oth

as

per

he

requirement.

What

are

vaccines

hat

prevent

ancers?

what

are

he

ncidences

f those

cancers

hat

can

be brought

downby hesevaccines?

9.

comment

on

economizing

ncological

management

or

patient

from

poor

socio-economical

trata.

10.

Describe

procedures

nvorved

n

commissioning

f

a

Linear

Accelerator.

up

3+4+3

5+5

5+5

3+3+4

5+5

5+5

5+5

1 0

5.

a.

b.

c.

a.

).

a.

b.

6.

7.

8.

a.

b.

1 0

POSSESSION/ASE

OF

CELL

PHONES

ORANYSUCH

ELECTRONIC

GADGETS

S

NOT

PERMITTED

INSIDE

THE EXAMINATION

IALL

1 0


2/5

FINALEXAM

DECEMBER

O1I

NATIONAL

OARDOF

EXAMINATIONS

RADIO

THERAPY

PAPER-

I

RTH/D/I1t41fi1

ime

:

3

hours

Max.Marks : 100

Aftempt

all

questions

n order.

Each

question

carries

10 marks.

1.

Whatare

he

components

f

Risk

Stratification

n

carcinoma

f

Prostate?

a. Components

b.

Description

f Groups

c. Briefly

bout herapy ecisions

2.

a.

What

are

the fundamentals

f

pre-operative

nd

post-

operativeadiotherapy?

b. Compare

oth

he strategies

n Carcinoma

ectum.

c. Mention

ew

results

f

mportant

rials.

3. Describe

adiotherapy

n

pleomorphic

denoma

f

parotid:

a.

lts ndications

b. lts

echnique

c.

Results

4.

what

is the

concept f

prophylactic

rradiation

n smail

ceil rung

cancer?

Briefly

ive

esults

f such

herapy.

5.

write

staging

system or

retinoblastoma.

numerate

reatment

modality

s

per

the stage

of

the disease

and

complications

f

.

various

adiotherapy

ethodsn

retinoblastoma.

6.

compare

he

physical

properties

f

any

five isotopes

sed n

Brachytherapy.

7. which

chemotherapy

rotocol

s

considered

afest

uring

econd

and

third

rimester f

pregnant

women

with

breast

cancer

and

why?

8. Describe arious hemotherapyegimensor relapsed

odgkin's

Lymphoma.

Enumerate

omponents

f

such

comprehensive

therapy.

9.

Discuss

ustification

f monoclonal

ntibodies

n

cancer

herapy.

Enumerate

various monoclonal

ntibodies

and

marignancies

treated

by them.

PaSSESSI0N/aSE

F

CELL?I:fr3\i;;';.1'rf,'i:ff;fflI:ricADcErs

IS

NorPERMITTED

3+4+3

4+3+3

4+4+2

t',t

5+5

4+3+3

5+5

5+5

5+5

P.T.O.

1 0


3/5

FINAL

EXAM

DECEMBER

011

NATIONAL

OARD

OF EXAMINATIONS

10.

a. What

s

carcinoma

eritonei?

4+3+3

b. Describe

arious

methods

of intra-peritoneal

hemotherapy

in

brief.

c.

Enumerate

rugs

n a

tab.-uhrolm

that can

be

given

ntra-

peritoneally

with

their relative

concentrations

when

compared

o

systemic

dministration.


4/5

FINAL

EXAM

DECEMBER

011

NATIONAL

OARD

OF

EXAIUINATIONS

PAPER-

II

Time

: 3 hours

Max.Marks : 100

RTH/D/I1t41ilta

Attempt

all

questions

n

order.

Each

question

carries10 marks

1.

Describe

EGF

andangiopoietin

s

applied

ncotherapeutics.

2.

Describe

ecent dvances

n management

f carcinoma

radder.

3.

What s

Internationalrognostic

ndex

or Hodgkin's

ymphoma?'

4.

Describe

he oncotherapeutic

se

of

thalidomide

long

with a

brief

note

on its

historical

se .

5.

what is

the rationalebehind

integrating

molecular

argeting

approaches

ith radiation?

Give

examples

f clinical

ituations

where

it

has

given

encouraging

esults?

Enlist

associated

complications.

6.

What

are recent

advances

in

screening

of oral

cancers?

Enumerate

riefly

he

gadgetry

nd

he Lab

echniques.

7.

What

are the recent

advances

n very

early

and very

ate

stage

cancers

of uterine

ervix?

8.

Briefly

describe

he

rationale

and

techniques

of

partiar

breast

-

irradiation

nd ts results.

9.

Describe

WHO

Ladder

of

pain

management.

What

do

you

understand

y

erm

Cyclical

nalgesics

10.

Discuss

riefly

n management

f cancer

f

pancreas.

POSSESSION/ASE

OF CELL PHONES

OR ANYSUCH

ELECTRONIC

GADGETS S

NOT PER *IITTED

INSIDE

THE

H(AMINATION

IIALL

5+5

1 0

1 0

8+2

4+3+3

4+3+3

5+5

3+3+4

8+2

1 0


5/5

FINALEXAM NATIONAL

OARD

OF

EXAMINATIONS

DECEMBER

0{1

RADIO

THERAPY

PAPER- V

Time

:3hours

RTH/D/l l l4 l l lV

Max.Marks

:

100

Attemptall

questions

n order.

Each

question

carries

10 marks.

Write short notes on :-

1.

a.

Decay

cheme f Cobalt 0

5+5

b.

Whatwill

be the activity f 12000

Curie

Cobalt=60

ourceafter

5

years?

2.

How

will

you

classify

Radiation

amage ?Enumerate

arious

5+5

methods f radiation

amage epair.

3.

What is

linear

quadratic

soeffect

model? How best

can we 5+5

utilizehismodality

linically?

4.

Describe how

anatomy and lymphatic

drainage

plays

an

5+5

important

ole n radiation

reatment

lanning?

Exemptify

t with

treatment f

glottic

arcinoma .

5. Describe

ow

to evaluate he

radiotherapy

lan generated

ith

10

respecto dose

volume istogram

ndbiological

ndices.

6. Definestereotactic adiosueryand stereotactic adiotherapy. 2+3+5

What

are

the radio-biologic

onsiderations

n relation

o

above?

Describe

n brief

adio-surgicaltechniques

mployed

n treatment

of tumour.

7. Discuss

n brief

cellsurvival

urveand ts mplications

n

radiation

5+5

research.

8. Describe

iotogical asisof various

CNS

umors. Draw

adiation

5+5

fieldsof craniospinal

adiation ith

demarcations.

9. What is immunohistochemistrynd how it formsthe basis of 4+6

identifying

ellof origin n

metastasis

f unknown

rigin?

10.

Enumerate

he conditions here

onizing

adiations

re

used n 5+5

non malignant

isease. Describe

reatment

lanning'and

ose

scheduleor

one

of them.

'

* { . { < *

POSSESSION/ASE

F CELL PHONES OR ANY

SUCH

ELECTRONIC

GADGETS

S NOT PERMITTED

I

INSTDE

THE

EXAMINATION

HALL

radio therapy dec11

Documents